Astrana Health, Inc. (NASDAQ:ASTH) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Astrana Health, Inc. (NASDAQ:ASTH) has been assigned an average rating of “Moderate Buy” from the eleven ratings firms that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and eight have issued a buy rating on the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $40.7778.

ASTH has been the subject of a number of research reports. Barclays dropped their price target on Astrana Health from $36.00 to $26.00 and set an “equal weight” rating for the company in a research note on Monday, November 24th. BTIG Research dropped their target price on Astrana Health from $45.00 to $40.00 and set a “buy” rating for the company in a research report on Monday, February 2nd. Zacks Research upgraded Astrana Health from a “strong sell” rating to a “hold” rating in a report on Monday, January 12th. Needham & Company LLC assumed coverage on Astrana Health in a research note on Friday, December 12th. They issued a “buy” rating and a $28.00 price objective for the company. Finally, TD Cowen dropped their price objective on shares of Astrana Health from $40.00 to $35.00 and set a “buy” rating for the company in a report on Monday, November 10th.

Astrana Health Trading Down 2.8%

ASTH opened at $21.10 on Friday. The company has a market cap of $1.19 billion, a P/E ratio of 111.06, a PEG ratio of 0.65 and a beta of 0.90. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.27. The company’s 50 day moving average is $24.47 and its 200-day moving average is $26.77. Astrana Health has a 1-year low of $20.12 and a 1-year high of $39.97.

Astrana Health (NASDAQ:ASTH) last issued its quarterly earnings data on Thursday, November 6th. The company reported $0.01 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.46). Astrana Health had a net margin of 0.33% and a return on equity of 1.26%. The company had revenue of $956.05 million during the quarter, compared to the consensus estimate of $952.83 million. During the same period in the previous year, the company earned $0.33 EPS. Astrana Health’s revenue for the quarter was up 99.7% on a year-over-year basis. Equities research analysts predict that Astrana Health will post 1.15 earnings per share for the current fiscal year.

Institutional Trading of Astrana Health

Institutional investors have recently modified their holdings of the business. Signaturefd LLC raised its position in Astrana Health by 57.9% during the 4th quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock worth $26,000 after purchasing an additional 388 shares during the last quarter. Amalgamated Bank increased its stake in shares of Astrana Health by 3.4% in the third quarter. Amalgamated Bank now owns 12,325 shares of the company’s stock valued at $349,000 after buying an additional 409 shares during the period. Thrivent Financial for Lutherans increased its stake in shares of Astrana Health by 1.5% in the third quarter. Thrivent Financial for Lutherans now owns 30,977 shares of the company’s stock valued at $878,000 after buying an additional 455 shares during the period. Principal Financial Group Inc. raised its position in shares of Astrana Health by 0.3% during the third quarter. Principal Financial Group Inc. now owns 222,985 shares of the company’s stock worth $6,322,000 after acquiring an additional 611 shares during the last quarter. Finally, Savant Capital LLC lifted its stake in shares of Astrana Health by 2.2% in the third quarter. Savant Capital LLC now owns 30,713 shares of the company’s stock worth $871,000 after acquiring an additional 649 shares during the period. Institutional investors own 52.77% of the company’s stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.